Drug Approval | August 24, 2023
Briefs: J B Chemicals & Pharmaceuticals updates and Torrent Pharmaceuticals
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
The company has reported total income of Rs. 2481 crores during the period ended December 31, 2022
Torrent Pharmaceuticals has reported total income of Rs. 2377 crores during the period ended June 30, 2022.
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
The company posted net profit of Rs.321 crores for the period ended June 30, 2020.
Ind-Ra expects chronic therapies to outpace IPM as compliance improves and lifestyle diseases rise
A PhD in Pharmaceutical Sciences, Dr Singh has led global regulatory audits, product validations, and quality systems spanning therapeutic formulations, dietary supplements, and functional foods
The capital was raised via multiple-tenure non-convertible debentures (NCDs) and commercial papers
Subscribe To Our Newsletter & Stay Updated
